{
  "company": {
    "name": "Okomera",
    "website": "https://okomera.com/",
    "record": "https://startuphistory.org/c/okomera.com"
  },
  "status": null,
  "history_since": "2020-11-27T06:38:01.000Z",
  "baseline": {
    "snapshot_id": "53297c3740b26c5309139b10ed67f32d2099c0b7f333921306f2c174867fc112",
    "observed_at": "2022-03-07T10:36:27.000Z",
    "headline": null,
    "description": "Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The \"test before you treat\" solution for every oncologist and patient.",
    "evidence": "https://web.archive.org/web/20220307103627/https://www.okomera.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:51:04.010Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2025-01-09T02:11:06.000Z",
      "variants": [
        {
          "headline": "Automated 3D organoid screening technology",
          "subhead": "Okomera is developing an innovative approach to accelerate the development of personalized cancer treatments. The technology allows to test a panel of potential therapies (chemotherapy, immunotherapy,",
          "observed_at": "2024-01-15T21:36:52.000Z",
          "evidence": "https://web.archive.org/web/20240115213652/https://www.okomera.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Automated 3D organoid screening technology",
          "subhead": "Okomera is developing an innovative approach to accelerate the development of personalized cancer treatments. The technology allows to test a panel of potential therapies (chemotherapy, immunotherapy,",
          "observed_at": "2024-11-02T16:55:19.000Z",
          "evidence": "https://web.archive.org/web/20241102165519/https://www.okomera.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Automated 3D organoid screening technology",
          "subhead": "Okomera is developing an innovative approach to accelerate the development of personalized cancer treatments. The technology allows to test a panel of potential therapies (chemotherapy, immunotherapy,",
          "observed_at": "2025-01-09T02:11:06.000Z",
          "evidence": "https://web.archive.org/web/20250109021106/https://www.okomera.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Automated 3D organoid screening technology",
      "subhead": "Okomera is developing an innovative approach to accelerate the development of personalized cancer treatments. The technology allows to test a panel of potential therapies (chemotherapy, immunotherapy,",
      "from": "2024-01-15T21:36:52.000Z",
      "to": "2025-01-09T02:11:06.000Z",
      "captures": 3,
      "evidence": "https://web.archive.org/web/20250109021106/https://www.okomera.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2024-01-15T21:36:52.000Z",
          "to": "2025-01-09T02:11:06.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:51:04.010Z",
      "variants": [
        {
          "headline": "Response is the ultimate biomarker",
          "subhead": "Okomera is developing an innovative approach to accelerate the development of personalized cancer treatments. The technology allows to test a panel of potential therapies (chemotherapy, immunotherapy,",
          "observed_at": "2026-07-10T07:53:54.000Z",
          "evidence": "https://web.archive.org/web/20260710075354/https://okomera.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Response is the ultimate biomarker",
          "subhead": "Okomera turns tumor response into treatment decisions. Its proprietary platform acts as a decentralized lab for clinicians and biopharma, transforming patient biopsies into miniaturized tumor avatars ",
          "observed_at": "2026-11-06T17:51:04.010Z",
          "evidence": "https://www.okomera.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Response is the ultimate biomarker",
      "subhead": "Okomera turns tumor response into treatment decisions. Its proprietary platform acts as a decentralized lab for clinicians and biopharma, transforming patient biopsies into miniaturized tumor avatars ",
      "from": "2026-07-10T07:53:54.000Z",
      "to": "2026-11-06T17:51:04.010Z",
      "captures": 2,
      "evidence": "https://www.okomera.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-07-10T07:53:54.000Z",
          "to": "2026-11-06T17:51:04.010Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-ee4baff614c227d8e08435954aa50ee37422f03ea083b6a7f2237024eaa1e7a8:53297c3740b26c5309139b10ed67f32d2099c0b7f333921306f2c174867fc112:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20201127063801/https://www.okomera.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2020-11-27T06:38:01.000Z",
        "to": "2022-03-07T10:36:27.000Z"
      },
      "evidence": "https://web.archive.org/web/20220307103627/https://www.okomera.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Okomera” company record, https://startuphistory.org/c/okomera.com"
}